Fosphenytoin

磷苯妥英

Report date: 2023/03/21 10:43:33
NME

Base Information

Drug NameFosphenytoin
Drug Alias NameFosphenytoinum磷苯妥英Fosphenytoin sodium hydrateFosphenytoin SodiumCereneu +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsCancer PainPainNeuralgia +[6] 
Global Approved IndicationsSeizuresEpilepsy, Tonic-ClonicEpilepsy
Approved Indications in ChinaSeizuresEpilepsy, Tonic-Clonic
Original Approved Country/TerritoryUnited States
Original Approved Date1996/08/05
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Nuberen Pharmaceutical Co LtdParke Davis Pharmaceutical Research Div Warner Lambert CoNobelpharma Co Ltd +[5] 
Inactive CompaniesLupin LtdXi'an Xintong Pharmaceutical Research Co Ltd
Active IndicationsPainSeizuresEpilepsy, Tonic-Clonic +[4] 
Inactive IndicationsCancer PainNeuralgia

Other Information

ATC CodeN03AB05
Related LinksWikipediaDrugBankKEGG